Everstone Said to Weigh Sale of $1 Billion Medical Device Firm

Everstone Capital, the private equity arm of Mumbai-based Everstone Group, is considering selling its health-care platform in Asia that could be valued at as much as $1 billion in a deal, according to people with knowledge of the matter.

The buyout firm has asked investment banks to submit proposals for Singapore-headquartered Everlife Holdings Pte, said the people, who asked not to be identified as the information is private. Everstone Capital is seeking a valuation of $500 million to $1 billion for Everlife, the people said, adding that some companies in the industry and private equity firms have shown ...